Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Nevirapine in Renal or Hepatic Dysfunction
NCT02184091Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 1999
- Primary completion
- Jul 1999
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of nevirapine in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the plasma concentration time curve up to 7 days, Maximum observed concentration up to 7 days and 5 more. Started Jan 1999; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02184091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184091.